Cellular Immunotherapy Market with COVID-19 Impact Analysis, By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, and TIL Therapy), Disease Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, and Renal Cell Carcinoma), End User, and By Region Size, Share & Forecast from 2022-2028
REPORT HIGHLIGHT
Cellular Immunotherapy Market size was valued at USD 3,880.1 Million in 2021, growing at a CAGR of 29.7% from 2022 to 2028.
Adoptive cell therapy, sometimes referred to as cellular immunotherapy, is a type of medical care that employs the immune system's cells to get rid of cancer. The immune system is able to identify and destroy malignant, damaged, or infected cells. Due to their capacity to connect to antigens on the surface of cancer cells, immune cells known as killer T cells attack malignant cells. Cellular immunotherapies make use of the killer T cells' inherent capacity to combat cancer cells. These T cells may not be present in sufficient numbers to successfully combat cancer cells and may occasionally become activated before doing so. Tumor-infiltrating lymphocyte (TIL) immunotherapy is one type of cell-based immunotherapy that targets these problems. Another type of cell-based immunotherapy known as CAR T-cell treatment involves reprogramming a patient's own T cells to detect and combat cancer.
Market Dynamics
The National Cancer Institute (NCI) and the Center of Excellence in Immunology (CEI) are two government organisations and research institutions that are increasingly supporting the development of cellular immunotherapies. This is one of the key factors boosting the market's expansion. For instance, to support the expansion of immunotherapy for the treatment of cancer, the CEI recruits experts from other organisations including the NCI and NIH. Additionally, the development of innovative immunotherapies for the treatment of cancer patients is a priority for the Surgery Branch of the Center for Cancer Research (CCR) of the National Cancer Institute.
The market has been significantly impacted by the COVID-19 pandemic. The pandemic's strict restrictions have slowed down clinical trials, delayed the licencing of new pharmaceuticals, and delayed cancer diagnoses, which has had an impact on the industry's growth. However, from the third quarter of 2021, COVID-19's impact started to wane in a number of nations, which helped the market gain momentum again.
Segmentation Analysis:
The Global Cellular Immunotherapy Market is segmented on the basis of Therapy type, Disease Indication, End User and Region.
The market is divided into five categories based on Therapy type: CART Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, and Others. The market was dominated by CAR T cell treatment, which is also anticipated to grow at the fastest rate over the projected period. A profitable product pipeline and fresh product approvals are to blame for this. Market participants have made significant investments in the research and development of novel CAR T cell therapy due to its optimistic therapeutic outcomes. There are more than 500 CAR T cell treatment trials running right now. In the upcoming years, it is anticipated that the approval of new goods and the following launches of such products will boost market growth. For instance, the FDA approved CARVYKTI (ciltacabtagene autoleucel) from Janssen Global Services, LLC in February 2022.
The market is divided into three categories based on end user: Hospitals, Cancer Institutes, and others. The Hospital End user segment is expected to dominate the global cellular immunotherapy market. The overall number of hospitalisations worldwide has increased due to the rising incidence of cancer, which has resulted in an increase in the number of patients in hospital settings. Furthermore, cellular immunotherapy infusion requires qualified medical personnel; these requirements are more appropriate for hospital settings, which further improves patient compliance.
Competitive Landscape:
The global market for Cellular Immunotherapy is made comprises of a number of both international and local producers, making it fairly competitive sectors in the world. A key trend among the key market player is the increase in M&As, collaborations, acquisitions, and finance. Companies can quickly broaden their regional reach and current product portfolio through M&A and partnership. For instance, in April 2020, Adicet Bio, Inc. announced merger with resTORbio, Inc. With the merger both companies will expand their presence in cellular immunotherapy R&D and development of novel allogeneic gamma-delta CAR-T cell therapy technology.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELLULAR IMMUNOTHERAPY MARKET KEY PLAYERS
- Bristol-Myers Squibb Company
- Novartis AG
- Gilead Sciences Inc. (Kite Pharma)
- Hoffmann-La Roche Ltd
- Merck KGaA
- GlaxoSmithKline plc.
- AstraZeneca
- Pfizer Inc.
- Johnson & Johnson
- Celyad
- Adicet Bio
GLOBAL CELLULAR IMMUNOTHERAPY MARKET, BY THERAPY TYPE
- CAR T Cell Therapy
- Dendritic Cell Therapy
- NK Cell Therapy
- TIL Therapy
GLOBAL CELLULAR IMMUNOTHERAPY MARKET, BY DISEASE INDICATION
- B-cell Malignancies
- Prostate Cancer
- Liver Cancer
- Renal Cell Carcinoma
- Others
GLOBAL CELLULAR IMMUNOTHERAPY MARKET, BY END USER
- Hospitals
- Cancer Institutes
- Others
GLOBAL CELLULAR IMMUNOTHERAPY MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Cellular Immunotherapy Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Market Snippet by Therapy Type
2.1.2. Market Snippet by Disease Indication
2.1.3. Market Snippet by End User
2.1.4. Market Snippet by Country
2.1.5. Market Snippet by Region
2.2. Competitive Insights
3. Cellular Immunotherapy Key Market Trends
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. Cellular Immunotherapy Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cellular Immunotherapy Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Cellular Immunotherapy Market Landscape
6.1. Market Share Analysis, 2021
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cellular Immunotherapy Market – By Therapy Type
7.1. Overview
7.1.1. Segment Share Analysis, By Therapy Type, 2021 & 2028 (%)
7.1.2. CAR T Cell Therapy
7.1.3. Dendritic Cell Therapy
7.1.4. NK Cell Therapy
7.1.5. TIL Therapy
8. Cellular Immunotherapy Market – By Disease Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Disease Indication, 2021 & 2028 (%)
8.1.2. B-cell Malignancies
8.1.3. Prostate Cancer
8.1.4. Liver Cancer
8.1.5. Renal Cell Carcinoma
8.1.6. Others
9. Cellular Immunotherapy Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2021 & 2028 (%)
9.1.2. Hospitals
9.1.3. Cancer Institutes
9.1.4. Others
10. Cellular Immunotherapy Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.2.4. North America Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.2.5. North America Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11. Key Vendor Analysis
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Bristol-Myers Squibb Company
11.2.2. Novartis AG
11.2.3. Gilead Sciences Inc. (Kite Pharma)
11.2.4. F. Hoffmann-La Roche Ltd
11.2.5. Merck KGaA
11.2.6. GlaxoSmithKline plc.
11.2.7. AstraZeneca
11.2.8. Pfizer Inc.
11.2.9. Johnson & Johnson
11.2.10. Celyad
11.2.11. Adicet Bio
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
